Kui Zhu

7.0k citations
131 papers · 4.5k indexed · 3 hit papers · h-index 35
Topics
Antibiotic Resistance in Bacteria (23 papers)Antimicrobial Peptides and Activities (14 papers)Bacteriophages and microbial interactions (13 papers)

In The Last Decade

Kui Zhu

126 papers receiving 4.5k citations

Hit Papers

A broad-spectrum antibiotic adjuvant reverses multidrug-r...2020202620222024202020212022100200300

Peers

Kui Zhu
Comparison fields: 5 of 140
  • Molecular Biology 2.0k
  • Molecular Medicine 671
  • Microbiology 640
  • Biomedical Engineering 598
  • Food Science 567
Replace Jianfeng Wang with:
Jianfeng Wang China
Rajendra Prasad India
Dacheng Wang China
Menghong Dai China
Lefu Lan China
Xuming Deng China
Abdelwahab Omri Canada
Yulian Wang China
Arumugam Veera Ravi India
Kui Zhu relative to Jianfeng Wang China Jianfeng Wang's profile →
Citations per field
00.5×2.9×
Jianfeng Wang · 1×
Citations per year

Countries citing papers authored by Kui Zhu

Since Specialization
Citations

This map shows the geographic impact of Kui Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kui Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kui Zhu more than expected).

Fields of papers citing papers by Kui Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kui Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kui Zhu. The network helps show where Kui Zhu may publish in the future.

Co-authorship network of co-authors of Kui Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Kui Zhu. A scholar is included among the top collaborators of Kui Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kui Zhu. Kui Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 4
3 0
4 2
5 1
6 3
7 2
8 6
9 19
10 14
11 3
12 16
13 29
14 17
15
Natural Products/Bioactive Compounds as a Source of Anticancer Drugsbreakdown →
160
16 76
17 6
18 74
19 32
20 13

About Kui Zhu

Kui Zhu is a scholar working on Molecular Medicine, Microbiology and Endocrinology, having authored 131 papers that have together received 4.5k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (23 papers), Antimicrobial Peptides and Activities (14 papers) and Bacteriophages and microbial interactions (13 papers). The work is most often cited by research in Molecular Medicine (671 citations), Microbiology (640 citations) and Food Science (567 citations). Kui Zhu has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Shuangyang Ding, Jianzhong Shen, Yuan Liu, Meirong Song, Xiaoyong Huang, Erwin Märtlbauer, Richard Dietrich, Yang Wang, Yangzhouyun Xie and Fei Liu. Their work appears in journals such as Cell, Journal of Biological Chemistry and Angewandte Chemie International Edition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026